Ophthalmic Surgical Devices Market Size, Share & Industry Analysis, By Surgery Type (Cataract Surgery Devices, Vitreoretinal Surgery Devices, Refractive Error Surgery Devices, Glaucoma Surgery Devices), By End-user (Hospitals, Ophthalmic Clinics, Others), and Regional Forecast, 2019-2026 (Includes COVID-19 Business Impact)

                                          
We have updated Ophthalmic Surgical Devices Market with respect to COVID-19 Business Impact.
Inquire before buying


This report focuses on the Ophthalmic Surgical Devices market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Ophthalmic Surgical Devices market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.


Global Ophthalmic Surgical Devices Market: Segment Analysis


The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.


Global Ophthalmic Surgical Devices Market: Regional Analysis


The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.


Global Ophthalmic Surgical Devices Market: Competitive Landscape


This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.
List of Companies Profiled

Alcon and Johnson and Johnson Services, Inc., Together Account for the Largest Share in the Market
Alcon, a part of Novartis AG, holds the highest share in this market. Following Alcon is Johnson and Johnson Services, Inc., holding the second dominating position in the ophthalmic surgical devices market share. Alcon has a wide range of product offerings that cover diverse ocular disorders including glaucoma, cataract, refractive errors, and dry eye. The company offers equipment and consumables targeted for the treatment of ocular diseases. Johnson and Johnson Services, Inc. also holds a significant share in the ophthalmic surgery devices market. The strategic acquisitions planned by Johnson and Johnson Service, Inc. has enabled the company to capture the market share in global ophthalmology diagnostics & surgical devices industry. Few of the predominant strategies followed by the key market players are constant innovation in glaucoma surgery, strategic partnerships, acquisition, among others. Other prominent players in the ophthalmic surgical devices market include ZEISS International, STAAR SURGICAL, Bausch & Lomb Incorporated, Glaukos, and others.

List Of Key Companies Covered:

  
Alcon (Part of Novartis AG)
  
Johnson and Johnson Services, Inc.
  
ZEISS International
  
Bausch & Lomb Incorporated
  
STAAR SURGICAL
  
Hoya Corporation
  
Glaukos
  
Allergan
  
New World Medical, Inc
  
Oertli Instrumente AG
  
Other Prominent Players

REPORT COVERAGE
The ophthalmic surgical devices market report offers an in-depth analysis of the market. It further provides details on the adoption of ophthalmic surgical devices across several regions. Information on trends, drivers, opportunities, threats, and restraints of the market can further help stakeholders to gain valuable insights into the ophthalmology surgical devices market. The report offers a detailed competitive landscape by presenting information on key players, along with their strategies, in the market.

The report presents a comprehensive assessment of the global ophthalmology surgical devices market by offering valuable insights, facts, industry-related information, and historical data. These include key insights such as the introduction of new products/approvals (by major players), number of cataract surgeries - for key countries, pipeline analysis, key industry developments - mergers, acquisitions, and partnerships, technological advancements in ophthalmic surgery among others.

REPOT SCOPE & Segmentation

Segmentation

By Surgery Type

Cataract Surgery Devices

  
Phacoemulsification Systems
  
Femtosecond Laser
  
Intraocular Lenses
  
Ophthalmic Viscoelastic Devices & Other Consumables

Vitreoretinal Surgery Devices

  
Equipment
  
Consumables

Refractive Error Surgery

  
Equipment
  
Consumables

Glaucoma Surgery

By End-user

  
Hospitals
  
Ophthalmic Clinics
  
Others

By Geography

  
North America (U.S. and Canada)
  
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  
Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)
  
Latin America (Brazil, Mexico, and Rest of Latin America)
  
Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)

INDUSTRY DEVELOPMENTS:

December 2019: Johnson and Johnson Vision, a division of Johnson and Johnson Services, Inc. received U.S FDA approval for TECNIS Toric II 1- Piece Intraocular Lens for the Cataract Patients

August 2018: Alcon announced an immediate voluntary recall of the companys CyPass Micro-Stent indicated to be used in glaucoma surgery owing to complications related to endothelial cell loss.

January 2018: Glaukos Corporation, a leader in the glaucoma surgery devices market, submitted an IDE application to the U.S FDA for the companys iStent infinite indicated to be used in the treatment of glaucoma.